[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:von-willebrand-disease-type-3":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":36,"states":37},"von Willebrand Disease, Type 3",4,2,[8,16,23,30],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06998524","A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease",[12],"Phase 3","RECRUITING","2026-08-26T02:17:19.710918Z","2026-05-05T02:43:29.366334Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06754852","A Study Assessing HMB-002 in Participants With Von Willebrand Disease",[20],"Phase 1\u002FPhase 2","2026-08-26T02:17:06.985283Z","2026-07-05T03:45:20.251661Z",{"nct_id":24,"title":25,"phases":26,"status":27,"updated_at":28,"content_modified":29},"NCT06883240","An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment",[],"ACTIVE_NOT_RECRUITING","2026-08-03T02:22:55.112436Z","2026-05-13T02:55:06.588397Z",{"nct_id":31,"title":32,"phases":33,"status":27,"updated_at":34,"content_modified":35},"NCT03655223","Early Check: Expanded Screening in Newborns",[],"2026-08-03T03:53:57.297126Z","2026-06-16T05:54:07.977837Z",[],[38,42],{"state":39,"count":40,"slug":41},"California",3,"california",{"state":43,"count":40,"slug":44},"Minnesota","minnesota"]